Search results
Douglas Grossman, MD, PhD, is an investigator in Huntsman Cancer Institute's (HCI) Melanoma Program and a Professor in the Department of Dermatology at the University of Utah School of Medicine. He is Co-Leader of the Melanoma center at HCI.
- Grossman Lab
Our work is focused on understanding how particular genes...
- Melanoma Research Labs
Principal Investigator: Douglas Grossman, MD, PhD. The...
- Grossman Lab
Our work is focused on understanding how particular genes promote (or inhibit) the development and progression of melanoma and to use this knowledge to develop novel strategies for reducing melanoma risk in susceptible individuals. Learn more about the Grossman lab’s research.
Principal Investigator: Douglas Grossman, MD, PhD. The Grossman Lab investigates genetic factors underlying melanoma risk and to develop novel strategies for melanoma prevention.
Douglas Grossman, MD, PhD, is an investigator in Huntsman Cancer Institute's (HCI) Melanoma Program and a Professor in the Department of Dermatology at the University of Utah School of Medicine. He is Co-Leader of the Melanoma center at HCI.
DOUGLAS GROSSMAN. Professor, Dermatology. Email u0260029@utah.edu. Phone 801-581-4682.
Sep 9, 2020 · Prognostic gene expression profile (GEP) testing for cutaneous melanoma (CM) is designed to predict recurrence or metastatic risk based on expression patterns of a selected panel of genes from the primary tumor.
Dr. Douglas Grossman, MD is a board certified dermatologist in Salt Lake City, Utah. He is affiliated with Primary Children's Hospital, University of Utah Health, and Intermountain Medical Center.
